Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Tablet Dedusting Process – V 2.0

Posted on By

Tablets: SOP for Tablet Dedusting Process – V 2.0

Standard Operating Procedure for Tablet Dedusting Process

Department Tablet
SOP No. SOP/TAB/039/2025
Supersedes SOP/TAB/039/2022
Page No. Page 1 of 5
Issue Date 22/08/2025
Effective Date 27/08/2025
Review Date 22/08/2026

1. Purpose

This SOP defines the procedure for the tablet dedusting process, which ensures that the tablets are free from loose powder or dust particles that may interfere with tablet appearance, quality, and subsequent packaging.

2. Scope

This SOP applies to all tablet formulations that require dedusting as part of the post-compression process. It includes procedures for effectively removing dust from tablets to maintain product integrity and quality.

3. Responsibilities

  • Manufacturing Personnel: Responsible for ensuring that tablets are properly dedusted before packaging and that the dedusting equipment is correctly set up and maintained.
  • Quality Control (QC): Responsible for verifying that the tablets meet the required cleanliness standards after dedusting and that no dust or residue is present on the tablets.
  • Quality Assurance (QA): Ensures that the dedusting process is conducted in accordance with this SOP and that the cleanliness of tablets is monitored and documented.

4. Accountability

The Production Manager is accountable for ensuring the proper execution of the tablet dedusting process. The QA

Manager is responsible for verifying that the dedusting process meets the required quality standards and for ensuring that proper documentation is maintained.

See also  Tablets: SOP for Risk-Based Monitoring of Manufacturing Processes - V 2.0

5. Procedure

5.1 Pre-Dedusting Setup

  1. Ensure that the tablets are fully compressed and ready for dedusting.
  2. Verify that the dedusting equipment, such as the dedusting machine or air blower, is clean and functioning properly. Ensure that it is calibrated and set to the correct speed and pressure levels as per the specifications for the formulation.
  3. Check the environmental conditions, such as room temperature and humidity, to ensure that they are suitable for the dedusting process.
  4. Ensure that all operators wear the required protective equipment (e.g., gloves, masks) to maintain hygiene during the process.

5.2 Dedusting Process

  1. Place the tablets into the dedusting machine, ensuring that the tablets are evenly distributed to avoid damaging the tablets during the dedusting process.
  2. Set the dedusting machine to the appropriate settings for the tablet size and type, ensuring the machine uses the correct airflow and brush settings to remove excess dust without damaging the tablets.
  3. Operate the dedusting machine to remove loose dust or powder from the tablet surface. The machine should utilize a combination of airflow and brushing to dislodge particles effectively.
  4. Monitor the process to ensure that all tablets are adequately dedusted, paying attention to the uniformity of dedusting to avoid uneven powder accumulation.
  5. If the tablets are not adequately cleaned, adjust the settings on the machine and repeat the dedusting process as necessary.
See also  Tablets: SOP for Vacuum Transfer Systems in Powder Handling - V 2.0

5.3 Post-Dedusting Inspection

  1. After the dedusting process, visually inspect the tablets for any remaining dust or particles. Tablets should have a clean surface without any loose powder or visible residue.
  2. Perform a random sample check by picking several tablets from the batch and inspecting them for cleanliness under appropriate lighting.
  3. Ensure that the tablets pass the cleanliness standards as outlined in the product specification sheet and the quality control testing criteria.
  4. If any tablets fail the cleanliness check, remove them from the batch and reprocess them by repeating the dedusting procedure.

5.4 Documentation and Record-Keeping

  1. Document all details of the dedusting process, including batch number, tablet type, dedusting settings, and any deviations or adjustments made during the process in the batch record (Annexure-1).
  2. Record any failure to meet the cleanliness standards in the deviation report (Annexure-2) and document any corrective actions taken.
  3. Store the batch records and inspection results for future reference, audits, and quality reviews.

5.5 Equipment Cleaning and Maintenance

  1. After each dedusting process, clean the dedusting machine to remove any residual dust or powder. Follow the equipment cleaning SOP to ensure proper maintenance of the machine.
  2. Inspect the dedusting machine regularly for any wear or damage to the brushes, air nozzles, or other components. Replace any parts that are worn or damaged to maintain optimal functionality.
See also  Tablets: SOP for Analytical Standards Preparation for Quality Control - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-1)
  2. Deviation Report (Annexure-2)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record

Batch Number Tablet Type Dedusting Settings Tablet Cleanliness Remarks
Batch 001 Tablet A Speed: 10, Pressure: 2.5 bar Pass Uniform dust removal
Batch 002 Tablet B Speed: 12, Pressure: 3.0 bar Pass Minor adjustment to speed

Annexure-2: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
23/07/2025 Batch 003 Uneven dust removal Adjusted dedusting machine speed John Doe

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Dedusting Parameters Optimized Process QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Preparing and Maintaining Audit Trail for EHS Activities
Next Post: SOP for Preparing Reports on Energy and Resource Conservation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version